Skip to main content

Table 1 The predictive values of clinical features and risk score

From: Systematic analysis of lncRNA–miRNA–mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer

Variables

Patients (N)

Univariate analysis

Multivariate analysis

HR (95% CI)

P

HR (95% CI)

P

Age

 < 60/≥ 60

572/506

1.67 (1.13–2.48)

0.010

2.46 (1.37–4.42)

0.003

Pathologic stage

 I–II/III–IV

799/279

2.47 (1.67-–3.66)

0.000

2.86 (1.15–7.11)

0.024

Stage T

 T1–T2/T3–T4

901/177

1.26 (0.8–1.97)

0.323

1.41 (0.59–3.35)

0.440

Stage N

 N0/NX

512/566

2.56 (1.65–3.95)

0.000

1.12 (0.53–2.37)

0.773

Stage M

 M0/MX

901/177

1.79 (1.05–3.07)

0.034

0.48 (0.17–1.33)

0.156

ER

 Negative/positive

232/796

0.58 (0.38–0.88)

0.011

1.15 (0.31–4.32)

0.837

PR

 Negative/positive

338/687

0.57 (0.38–0.86)

0.007

0.54 (0.2–1.47)

0.226

Her2

 Negative/positive

552/163

2.3 (1.29–4.1)

0.005

2.24 (1.06–4.72)

0.034

Triple negative

 No/yes

598/112

1.59 (0.82–3.07)

0.168

1.69 (0.46–6.19)

0.428

Risk score

 Low/high

593/593

2.16 (1.42–3.29)

0.000

2.26 (1.15–4.43)

0.017

  1. HR hazard ratio, CI confidence interval